Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Medical Device Regulation in 1996: Continued Progress

This article was originally published in Clinica

Executive Summary

In 1996, the US FDA's Center for Devices and Radiological Health (CDRH) introduced several initiatives to meet both industry and congressional concerns regarding the delay in the introduction of new medical technologies to the marketplace. Major enforcement and compliance initiatives included the long awaited publication of the new quality system regulation (QSR) on October 7, 1996, and the implementation of the new medical device reporting (MDR) regulation. In addition, Congress finally enacted the FDA Export Reform and Enhancement Act of 1996 to allow easier export of unapproved medical devices, drugs, and biologics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089884

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel